{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:52:14Z","timestamp":1792176734058,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.biocel.2021.106051","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T11:26:39Z","timestamp":1627730799000},"page":"106051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7021-3779","authenticated-orcid":false,"given":"S.","family":"Bindhya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1608-0538","authenticated-orcid":false,"given":"C.","family":"Sidhanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-5501","authenticated-orcid":false,"given":"S.","family":"Krishnapriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-2957","authenticated-orcid":false,"given":"Manoj","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4671-8099","authenticated-orcid":false,"given":"T.S.","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2021.106051_bib0005","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/humrep\/des284","article-title":"Methylation profile of the promoters of Nanog and Oct4 in ICSI human embryos","volume":"27","author":"Al-Khtib","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.biocel.2021.106051_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molmed.2008.12.003","article-title":"Induced pluripotent stem cells: current progress and potential for regenerative medicine","volume":"15","author":"Amabile","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biocel.2021.106051_bib0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12015-016-9662-8","article-title":"Detailed characterisation of human induced pluripotent stem cells manufactured for therapeutic applications","volume":"12","author":"Baghbaderani","year":"2016","journal-title":"Stem Cell Rev Rep."},{"key":"10.1016\/j.biocel.2021.106051_bib0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.onc.1209827","article-title":"RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer","volume":"26","author":"Bignone","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2021.106051_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biocel.2018.12.008","article-title":"Induced pluripotent stem cells: a new strategy to model human cancer","volume":"107","author":"Bindhya","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biocel.2021.106051_bib0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.1783","article-title":"A functionally characterised test set of human induced pluripotent stem cells","volume":"29","author":"Boulting","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biocel.2021.106051_bib0035","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1038\/srep17258","article-title":"The molecular karyotype of 25 clinical-grade human embryonic stem cell lines","volume":"5","author":"Canham","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biocel.2021.106051_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.biocel.2021.106051_bib0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2021.106051_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1022913015916","article-title":"Mycoplasma contamination of cell cultures: incidence, sources, effects, detection, elimination, prevention","volume":"39","author":"Drexler","year":"2002","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biocel.2021.106051_bib0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2012.10.023","article-title":"Ovarian cancer stem cells: working towards the root of stemness","volume":"338","author":"Foster","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biocel.2021.106051_bib0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00280-014-2581-y","article-title":"Treatment of ovarian cancer beyond chemotherapy: are we hitting the target?","volume":"75","author":"Garces","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biocel.2021.106051_bib0065","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/REP-14-0234","article-title":"Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm","volume":"149","author":"Garson","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.biocel.2021.106051_bib0070","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/nar\/gks1305","article-title":"Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells","volume":"41","author":"Grabundzija","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biocel.2021.106051_bib0075","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/nprot.2012.097","article-title":"Primary culture and immortalisation of human fallopian tube secretory epithelial cells","volume":"7","author":"Karst","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biocel.2021.106051_bib0080","doi-asserted-by":"crossref","first-page":"30901","DOI":"10.1074\/jbc.M203563200","article-title":"Identification of Glis1, a novel Gli-related, Kr\u00fcppel-like zinc finger protein containing transactivation and repressor functions","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biocel.2021.106051_bib0085","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/bjc.2016.311","article-title":"PARP inhibitors for BRCA1\/2-mutated and sporadic ovarian cancer: current practice and future directions","volume":"115","author":"Konecny","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biocel.2021.106051_bib0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The Origin and pathogenesis of epithelial ovarian cancer-a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.biocel.2021.106051_bib0095","first-page":"6166","article-title":"Characterisation and properties of nine human ovarian adenocarcinoma cell lines","volume":"48","author":"Langdon","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2021.106051_bib0100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cell.2015.02.045","article-title":"Modeling familial cancer with induced pluripotent stem cells","volume":"161","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2021.106051_bib0105","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.4161\/cc.10.21.17834","article-title":"Glis1, a unique pro-reprogramming factor, may facilitate clinical applications of iPSC technology","volume":"10","author":"Maekawa","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biocel.2021.106051_bib0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature10106","article-title":"Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1","volume":"474","author":"Maekawa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2021.106051_bib0115","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1096\/fj.05-4480fje","article-title":"Inactivation of p16INK4a (inhibitor of cyclin-dependent kinase 4A) immortalises primary human keratinocytes by maintaining cells in the stem cell compartment","volume":"20","author":"Maurelli","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.biocel.2021.106051_bib0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4161\/cbt.5.4.2521","article-title":"Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors","volume":"5","author":"McClanahan","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biocel.2021.106051_bib0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1073\/pnas.0912407107","article-title":"Defined factors induce reprogramming of gastrointestinal cancer cells","volume":"107","author":"Miyoshi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biocel.2021.106051_bib0130","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ymthe.2005.01.005","article-title":"Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation","volume":"11","author":"Mostoslavsky","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biocel.2021.106051_bib0135","series-title":"Analyzing Data with GraphPad Prism","first-page":"225","author":"Motulsky","year":"1999"},{"key":"10.1016\/j.biocel.2021.106051_bib0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1574888X11666160607211436","article-title":"Cancer stem cells - are surface markers alone sufficient?","volume":"12","author":"Nagare","year":"2017","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.biocel.2021.106051_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112009","article-title":"ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo","volume":"392","author":"Nagare","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biocel.2021.106051_bib0150","first-page":"1","article-title":"Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours","author":"Nagare","year":"2020","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.biocel.2021.106051_bib0155","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4161\/epi.6.1.13433","article-title":"NANOG promoter methylation and expression correlation during normal and malignant human germ cell development","volume":"6","author":"Nettersheim","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.biocel.2021.106051_bib0160","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/onc.2012.614","article-title":"Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors","volume":"33","author":"Nishi","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2021.106051_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013017","article-title":"Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts","volume":"5","author":"Nishino","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2021.106051_bib0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1470-2045(14)71135-0","article-title":"Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial","volume":"16","author":"Oza","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biocel.2021.106051_bib0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jcb.23391","article-title":"A Simple and economical route to generate functional hepatocyte\u2010like cells from hESCs and their application in evaluating alcohol induced liver damage","volume":"113","author":"Pal","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biocel.2021.106051_bib0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molmed.2012.04.001","article-title":"iPSCs from cancer cells: challenges and opportunities","volume":"18","author":"Ramos-Mejia","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biocel.2021.106051_bib0185","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/en.2011-2123","article-title":"Minireview: human ovarian cancer: biology, current management, and paths to personalising therapy","volume":"153","author":"Romero","year":"2012","journal-title":"Endocrinology"},{"issue":"16","key":"10.1016\/j.biocel.2021.106051_bib0190","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1158\/0008-5472.CAN-09-1178","article-title":"Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma","volume":"69","author":"Sakai","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2021.106051_bib0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1634\/theoncologist.2014-0302","article-title":"Breaking down the evidence for bevacizumab in ovarian cancer","volume":"20","author":"Shu","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.biocel.2021.106051_bib0200","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biocel.2021.106051_bib0205","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12015-012-9359-6","article-title":"Novel live alkaline phosphatase substrate for identification of pluripotent stem cells","volume":"8","author":"Singh","year":"2012","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.biocel.2021.106051_bib0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/cell.2019.0005","article-title":"Analysis of human stem cell transcription factors","volume":"21","author":"Sneha","year":"2019","journal-title":"Cell Reprogram."},{"key":"10.1016\/j.biocel.2021.106051_bib0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/stem.255","article-title":"Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector","volume":"28","author":"Sommer","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.biocel.2021.106051_bib0220","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1101\/gad.1963910","article-title":"Induced pluripotency: history, mechanisms, and applications","volume":"24","author":"Stadtfeld","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.biocel.2021.106051_bib0225","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.biocel.2021.106051_bib0230","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2021.106051_bib0235","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nature08285","article-title":"Immortalisation eliminates a roadblock during cellular reprogramming into iPS cells","volume":"460","author":"Utikal","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2021.106051_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068187","article-title":"Ovarian cancer stem cells are enriched inside population and aldehyde dehydrogenase bright overlapping population","volume":"8","author":"Yasuda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2021.106051_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-05519-2","article-title":"Directed differentiation of human induced pluripotent stem cells into fallopian tube epithelium","volume":"7","author":"Yucer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biocel.2021.106051_bib0250","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterisation of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135727252100131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135727252100131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:19:24Z","timestamp":1761203964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135727252100131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":50,"alternative-id":["S135727252100131X"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2021.106051","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2021.106051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106051"}}